{
    "nctId": "NCT03894410",
    "briefTitle": "Real World Study of Lapatinib Among Metastatic Breast Cancer Patients",
    "officialTitle": "Real World Study of Lapatinib Among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 242,
    "primaryOutcomeMeasure": "PFS",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who were treated with Lapatinib between June 2014 to June 2018.\n* Patients experienced progression on prior trastuzumab-containing regimens and a taxane.\n* Complete medical history was available.\n\nExclusion Criteria:\n\n* Medical history was incomplete.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}